Preservation and Expansion of Current Domestic Capacities for Laboratory-Based Testing and Manufacturing of Over-The-Counter (OTC) Rapid Antigen and Point-Of-Care (POC) Nucleic Acid Amplification Tests (NAATs)
75A50122N00017
The COVID-19 pandemic has demonstrated how important a robust and resilient public health industrial base is in ensuring the health and security of the United States. It also highlighted the need for ...